Blood and Lymphatic System - Thromboembolism Drug Pipeline Report
Posted on: Monday, 16 July 2007, 09:13 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c62832) has announced the addition of Blood and Lymphatic System - Thromboembolism Drug Pipeline Report to their offering.
"Blood and Lymphatic System - Thromboembolism Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of thromboembolism drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Content Outline:
Thromboembolism Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Thromboembolism Projects
--Top 20 companies in early stage Thromboembolism Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c62832
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Peregrine Completes Enrollment in First Stage of Phase II Cancer Trial
- Noble Energy Starts Production From Second Phase of Dumbarton Development
- PSTS China to Commence Production Expansion Project
- BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
- Toreador Announces Start of Production From Dogu Ayazli Platform, Provides Operational Update and Preliminary Second Phase Development Plan Offshore Turkey
- ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial
- Indiana Health Information Exchange Selected to Participate in First Phase Development of RHIO Best Practices
- Pro-Pharmaceuticals Completes Patient Enrollment in Stage 1 of Phase II Colorectal Cancer Trial Evaluating DAVANAT(R) With 5-FU
- BigLever Software Helps Bridge the Communication Gap Between Product Marketing and Software Development to Streamline Product Line Evolution
- SurModics Enters into Agreement With University of Arizona to Develop Advanced Medical Therapies
User Comments (0)
RSS Feeds